Neurogenic orthostatic hypotension in Parkinson’s disease: evaluation, management, and emerging role of droxidopa

References

• SenardJMRaiSLapeyre-MestreMPrevalence of orthostatic hypotension in Parkinson’s diseaseJ Neurol Neurosurg Psychiatry19976355845899408097
   PubMed Web of Science ®Google Scholar
• AllcockLMUllyartKKennyRABurnDJFrequency of orthostatic hypotension in a community based cohort of patients with Parkinson’s diseaseJ Neurol Neurosurg Psychiatry200475101470147115377699
   PubMed Web of Science ®Google Scholar
• SithinamsuwanPOrrawanhanothaiPThithumKOrthostatic hypotension: a non-motor complication assessment in 82 patients with idiopathic Parkinson’s disease in Phramongkutklao HospitalJ Med Assoc Thai201093Suppl 6S93S9921280520
   PubMedGoogle Scholar
• JainSGoldsteinDSCardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesisNeurobiol Dis201246357258022094370
   PubMed Web of Science ®Google Scholar
• HaADBrownCHYorkMKJankovicJThe prevalence of symptomatic orthostatic hypotension in patients with Parkinson’s disease and atypical parkinsonismParkinsonism Relat Disord201117862562821689962
   PubMed Web of Science ®Google Scholar
• MathiasCJTo stand on one’s own legsClin Med20022323724512108475
   PubMed Web of Science ®Google Scholar
• SharabiYImrichRHolmesCPechnikSGoldsteinDSGeneralized and neurotransmitter-selective noradrenergic denervation in Parkinson’s disease with orthostatic hypotensionMov Disord200823121725173218661549
   PubMed Web of Science ®Google Scholar
• SchatzIJOrthostatic hypotension. I. Functional and neurogenic causesArch Intern Med198414447737776370161
   PubMedGoogle Scholar
• FreemanRWielingWAxelrodFBConsensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndromeClin Auton Res2011212697221431947
   PubMed Web of Science ®Google Scholar
• FreemanRClinical practice. Neurogenic orthostatic hypotensionN Engl J Med2008358661562418256396
   PubMed Web of Science ®Google Scholar
• SenardJMPathakANeurogenic orthostatic hypotension of Parkinson’s disease: what exploration for what treatment?Rev Neurol (Paris)20101661077978420817229
   PubMed Web of Science ®Google Scholar
• GoldsteinDSSharabiYNeurogenic orthostatic hypotension: a pathophysiological approachCirculation2009119113914619124673
   PubMed Web of Science ®Google Scholar
• GoodallMCHarlanWRJrAltonHDecreased noradrenaline (norepinephrine) synthesis in neurogenic orthostatic hypotensionCirculation19683835926035673610
   PubMed Web of Science ®Google Scholar
• GoldsteinDSPolinskyRJGartyMPatterns of plasma levels of catechols in neurogenic orthostatic hypotensionAnn Neurol19892645585632510587
   PubMed Web of Science ®Google Scholar
• ImrichREldadahBABenthoOFunctional effects of cardiac sympathetic denervation in neurogenic orthostatic hypotensionParkinsonism Relat Disord200915212212718514012
   PubMed Web of Science ®Google Scholar
• SharabiYGoldsteinDSMechanisms of orthostatic hypotension and supine hypertension in Parkinson diseaseJ Neurol Sci20113101–212312821762927
   PubMed Web of Science ®Google Scholar
• BonuccelliULucettiCDel DottoPOrthostatic hypotension in de novo Parkinson diseaseArch Neurol200360101400140414568810
   PubMedGoogle Scholar
• MilazzoVDi StefanoCServoSZibettiMLopianoLMauleSNeurogenic orthostatic hypotension as the initial feature of Parkinson diseaseClin Auton Res201222420320622562219
   PubMed Web of Science ®Google Scholar
• KaufmannHNahmKPurohitDWolfeDAutonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodiesNeurology20046361093109515452307
   PubMed Web of Science ®Google Scholar
• OkaHToyodaCYogoMMochioSCardiovascular dysautonomia in de novo Parkinson’s disease without orthostatic hypotensionEur J Neurol201118228629220602633
   PubMed Web of Science ®Google Scholar
• GoldsteinDSHolmesCSharabiYBrentzelSEisenhoferGPlasma levels of catechols and metanephrines in neurogenic orthostatic hypotensionNeurology20036081327133212707437
   PubMed Web of Science ®Google Scholar
• GoldsteinDSHolmesCPatronasNKopinIJCerebrospinal fluid levels of catechols in patients with neurogenic orthostatic hypotensionClin Sci (Lond)2003104664965412540289
   PubMed Web of Science ®Google Scholar
• SchatzIJOrthostatic hypotension. II. Clinical diagnosis, testing, and treatmentArch Intern Med19841445103710416143541
   PubMedGoogle Scholar
• LowPASingerWManagement of neurogenic orthostatic hypotension: an updateLancet Neurol20087545145818420158
   PubMed Web of Science ®Google Scholar
• ZiemssenTReichmannHCardiovascular autonomic dysfunction in Parkinson’s diseaseJ Neurol Sci20102891–2748019740484
   PubMed Web of Science ®Google Scholar
• OmboniSSmitAAvan LieshoutJJSettelsJJLangewoutersGJWielingWMechanisms underlying the impairment in orthostatic tolerance after nocturnal recumbency in patients with autonomic failureClin Sci (Lond)2001101660961811724647
   PubMed Web of Science ®Google Scholar
• LipsitzLARyanSMParkerJAFreemanRWeiJYGoldbergerALHemodynamic and autonomic nervous system responses to mixed meal ingestion in healthy young and old subjects and dysautonomic patients with postprandial hypotensionCirculation19938723914008425288
   PubMed Web of Science ®Google Scholar
• LipsitzLAPluchinoFCWeiJYMinakerKLRoweJWCardiovascular and norepinephrine responses after meal consumption in elderly (older than 75 years) persons with postprandial hypotension and syncopeAm J Cardiol19865898108153766423
   PubMed Web of Science ®Google Scholar
• PathakALapeyre-MestreMMontastrucJLSenardJMHeat-related morbidity in patients with orthostatic hypotension and primary autonomic failureMov Disord20052091213121915954131
   PubMed Web of Science ®Google Scholar
• SenardJMBrefel-CourbonCRascolOMontastrucJLOrthostatic hypotension in patients with Parkinson’s disease: pathophysiology and managementDrugs Aging200118749550511482743
   PubMed Web of Science ®Google Scholar
• MecoGPratesiLBonifatiVCardiovascular reflexes and autonomic dysfunction in Parkinson’s diseaseJ Neurol199123841951991895149
   PubMed Web of Science ®Google Scholar
• LangAEAcute orthostatic hypotension when starting dopamine agonist therapy in parkinson disease: the role of domperidone therapyArch Neurol200158583511346387
   PubMedGoogle Scholar
• WoodLDClinical review and treatment of select adverse effects of dopamine receptor agonists in Parkinson’s diseaseDrugs Aging201027429531020359261
   PubMed Web of Science ®Google Scholar
• Jamnadas-KhodaJKoshySMathiasCJMuthaneUBRagothamanMDodaballapurSKAre current recommendations to diagnose orthostatic hypotension in Parkinson’s disease satisfactory?Mov Disord200924121747175119562759
   PubMed Web of Science ®Google Scholar
• StuebnerEVichayanratELowDAMathiasCJIsenmannSHaenschCATwenty-four hour non-invasive ambulatory blood pressure and heart rate monitoring in Parkinson’s diseaseFront Neurol201344923720648
   PubMed Web of Science ®Google Scholar
• PodaRGuaraldiPSolieriLStanding worsens cognitive functions in patients with neurogenic orthostatic hypotensionNeurol Sci201233246947321894556
   PubMed Web of Science ®Google Scholar
• KaufmannHMalamutRNorcliffe-KaufmannLRosaKFreemanRThe Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scaleClin Auton Res2012222799022045363
   PubMed Web of Science ®Google Scholar
• HillenMEWagnerMLSageJI“Subclinical” orthostatic hypotension is associated with dizziness in elderly patients with Parkinson diseaseArch Phys Med Rehabil19967777107128670000
   PubMed Web of Science ®Google Scholar
• CamilleriMMalageladaJRStanghelliniVFealeyRDShepsSGGastrointestinal motility disturbances in patients with orthostatic hypotensionGastroenterology1985886185218593996842
   PubMed Web of Science ®Google Scholar
• CersosimoMGBenarrochEEAutonomic involvement in Parkinson’s disease: pathology, pathophysiology, clinical features and possible peripheral biomarkersJ Neurol Sci20123131–2576322001247
   PubMed Web of Science ®Google Scholar
• KopinIJPolinskyRJOliverJAOddershedeIREbertMHUrinary catecholamine metabolites distinguish different types of sympathetic neuronal dysfunction in patients with orthostatic hypotensionJ Clin Endocrinol Metab19835736326376874892
   PubMed Web of Science ®Google Scholar
• LowPATomaliaVAParkKJAutonomic function tests: some clinical applicationsJ Clin Neurol2013911823346153
   PubMed Web of Science ®Google Scholar
• GurevichTYGroozmanGBGiladiNDroryVEHausdorffJMKorczynADR-R interval variation in Parkinson’s disease and multiple system atrophyActa Neurol Scand2004109427627915016010
   PubMed Web of Science ®Google Scholar
• HaenschCALerchHJorgJIsenmannSCardiac denervation occurs inde-pendent of orthostatic hypotension and impaired heart rate variability in Parkinson’s diseaseParkinsonism Relat Disord200915213413718515170
   PubMed Web of Science ®Google Scholar
• SmitAAWielingWOpfer-GehrkingTLvan Emmerik-LeveltHMLowPAPatients’ choice of portable folding chairs to reduce symptoms of orthostatic hypotensionClin Auton Res19999634134410638808
   PubMed Web of Science ®Google Scholar
• JordanJShannonJRBlackBKThe pressor response to water drinking in humans: a sympathetic reflex?Circulation2000101550450910662747
   PubMed Web of Science ®Google Scholar
• Z’GraggenWJHessCWHummAMAcute fluid ingestion in the treatment of orthostatic intolerance – important implications for daily practiceEur J Neurol201017111370137620412295
   PubMed Web of Science ®Google Scholar
• BouvetteCMMcPheeBROpfer-GehrkingTLLowPARole of physical countermaneuvers in the management of orthostatic hypotension: efficacy and biofeedback augmentationMayo Clin Proc19967198478538790259
   PubMed Web of Science ®Google Scholar
• SmitAAWielingWFujimuraJUse of lower abdominal compression to combat orthostatic hypotension in patients with autonomic dysfunctionClin Auton Res200414316717515241645
   PubMed Web of Science ®Google Scholar
• PodoleanuCMaggiRBrignoleMLower limb and abdominal compression bandages prevent progressive orthostatic hypotension in elderly persons: a randomized single-blind controlled studyJ Am Coll Cardiol20064871425143217010806
   PubMed Web of Science ®Google Scholar
• van LieshoutJJten HarkelADWielingWFludrocortisone and sleeping in the head-up position limit the postural decrease in cardiac output in autonomic failureClin Auton Res2000101354210750642
   PubMed Web of Science ®Google Scholar
• HicklerRBThompsonGRFoxLMHamlinJT3rdSuccessful treatment of orthostatic hypotension with 9-alpha-fluorohydrocortisoneN Engl J Med195926178879114401690
   PubMed Web of Science ®Google Scholar
• WrightRAKaufmannHCPereraRA double-blind, dose-response study of midodrine in neurogenic orthostatic hypotensionNeurology19985111201249674789
   PubMed Web of Science ®Google Scholar
• JankovicJGildenJLHinerBCNeurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrineAm J Med199395138487687093
   PubMed Web of Science ®Google Scholar
• LowPAGildenJLFreemanRShengKNMcElligottMAEfficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study GroupJAMA199727713104610519091692
   PubMed Web of Science ®Google Scholar
• SingerWSandroniPOpfer-GehrkingTLPyridostigmine treatment trial in neurogenic orthostatic hypotensionArch Neurol200663451351816476804
   PubMedGoogle Scholar
• PereraRIsolaLKaufmannHEffect of recombinant erythropoietin on anemia and orthostatic hypotension in primary autonomic failureClin Auton Res1995542112138520216
   PubMed Web of Science ®Google Scholar
• HoeldtkeRDStreetenDHTreatment of orthostatic hypotension with erythropoietinN Engl J Med199332996116158341335
   PubMed Web of Science ®Google Scholar
• MathiasCJFosbraeyPda CostaDFThornleyABannisterRThe effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failureBr Med J (Clin Res Ed)19862936543353354
   PubMedGoogle Scholar
• AbateGPolimeniRMCuccurulloFPudduPLenziSEffects of indomethacin on postural hypotension in ParkinsonismBr Med J19792620314661468393356
   PubMedGoogle Scholar
• OnrotJGoldbergMRBiaggioniIHollisterASKingaidDRobertsonDHemodynamic and humoral effects of caffeine in autonomic failure. Therapeutic implications for postprandial hypotensionN Engl J Med198531395495543894971
   PubMed Web of Science ®Google Scholar
• LahrmannHCortelliPHilzMMathiasCJStruhalWTassinariMEFNS guidelines on the diagnosis and management of orthostatic hypotensionEur J Neurol200613993093616930356
   PubMed Web of Science ®Google Scholar
• OnrotJGoldbergMRBiaggioniIWileyRGHollisterASRobertsonDOral yohimbine in human autonomic failureNeurology19873722152203808301
   PubMed Web of Science ®Google Scholar
• Fouad-TaraziFMOkabeMGorenHAlpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotensionAm J Med19959966046107503082
   PubMed Web of Science ®Google Scholar
• OkamotoLEShibaoCGamboaASynergistic effect of norepinephrine transporter blockade and alpha-2 antagonism on blood pressure in autonomic failureHypertension201259365065622311903
   PubMed Web of Science ®Google Scholar
• FreemanRLandsbergLThe treatment of orthostatic hypotension with dihydroxyphenylserineClin Neuropharmacol19911442963041913697
   PubMed Web of Science ®Google Scholar
• KaufmannHSaadiaDVoustianioukANorepinephrine precursor therapy in neurogenic orthostatic hypotensionCirculation2003108672472812885750
   PubMed Web of Science ®Google Scholar
• GoldsteinDSL-Dihydroxyphenylserine (L-DOPS): a norepinephrine prodrugCardiovasc Drug Rev2006243–418920317214596
   PubMedGoogle Scholar
• KaufmannHCould treatment with DOPS do for autonomic failure what DOPA did for Parkinson’s disease?Neurology1996476137013718960711
   PubMed Web of Science ®Google Scholar
• NarabayashiHNakanishiTTherapeutic effects of L-DOPS in Parkinson’s disease, double-blind comparative study against placebo as control in patients with long-term levodopa therapyClin Eval198715423457
   Google Scholar
• YanagisawaNIkedaSHashimotoTEffects of L-threo-Dops on orthostatic hypotension in Parkinson’s diseaseNo To Shinkei1998502157163 Japanese9513205
   PubMedGoogle Scholar
• MathiasCJSenardJMCortelliPA double-blind, randomized, placebo-controlled study to determine the efficacy and safety of droxidopa in the treatment of orthostatic hypotension associated with multiple system atrophy and Parkinson’s diseaseClin Auton Res200717272
   Google Scholar
• GoldsteinDSHolmesCKaufmannHFreemanRClinical pharmacokinetics of the norepinephrine precursor L-threo-DOPS in primary chronic autonomic failureClin Auton Res200414636336815666063
   PubMed Web of Science ®Google Scholar
• KaufmannHMathiasCFreemanRLowPBiaggioniIDroxidopa Study GroupTreatment with droxidopa – a phase III multinational, placebo-controlled, parallel group, withdrawal-design study in subjects with neurogenic orthostatic hypotension and non-diabetic autonomic neuropathyClin Auton Res200919281
   Google Scholar
• KaufmannHFreemanRBiaggioniILowPPedderSHewittAMathiasCTreatment of neurogenic orthostatic hypotension: results from a multi-center, double-blind, randomized, placebo-controlled, parallel group, induction design studyNeurology201278PL02.001
   Web of Science ®Google Scholar
• IsaacsonSShillHVerninoSCioffiCHutchmanRDurability of effect with long-term, open-label droxidopa treatment in patients with symptomatic neurogenic orthostatic hypotension (NOH 303)Mov Disord201227S424S425
   Web of Science ®Google Scholar
• KaufmannHKlosKHutchmanRIsaacsonSEffects of droxidopa (Northera™) on 24 hour blood pressure (BP) in patients with symptomatic neurogenic orthostatic hypotension (NOH)Mov Disord201025S405S406
   PubMedGoogle Scholar
• ShillHVerninoSHutchmanRAdkinsLIsaacsonSA multicenter, open-label study to assess the long-term safety of droxidopa in patients with symptomatic neurogenic orthostatic hypotension (NOH 304)Mov Disord201227S428
   PubMed Web of Science ®Google Scholar
• IsaacsonSHHauserRASzakacsCBNCioffiCCDroxidopa treatment impact on orthostatic symptoms and standing systolic blood pressure in patients with Parkinson’s disease and symptomatic neurogenic orthostatic hypotension: Study 306Neurology201380 Emerging Science Abstract 010
   PubMed Web of Science ®Google Scholar
• IsaacsonSHauserRASzakacsCBNCioffiCCImpact of droxidopa treatment in patients with Parkinson’s disease and symptomatic neurogenic orthostatic hypotension (study 306)Mov Disord201328Suppl 1468
   Google Scholar
• HauserRASchwietermanWIsaacsonSImpact of treatment with droxidopa in repeat fallers with Parkinson’s disease and symptomatic neurogenic orthostatic hypotension (NOH 306A)Mov Disord201227S423
   Web of Science ®Google Scholar
• BiaggioniILowPRowseGKaufmannHAnalysis of efficacy in patients with symptomatic neurogenic orthostatic hypotension treated with droxidopa and dopa-decarboxylase inhibitorsMov Disord201227S422S423
   Web of Science ®Google Scholar
• LeWittPGornySAnalysis of efficacy and safety outcomes in patients treated with droxidopa in combination with other drug classesMov Disord201227S425S426
   Web of Science ®Google Scholar
• LowPNelsonJStacyMSafety and efficacy of droxidopa in patients previously treated with midodrineMov Disord201227S426
   Web of Science ®Google Scholar
• MathiasCLowPFreemanRHewittLKaufmannHIntegrated efficacy analysis of droxidopa in 2 double-blind, placebo-controlled Phase 3 studies in patients with neurogenic orthostatic hypotensionMov Disord201227S426
   Web of Science ®Google Scholar